NCT01426425

Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

ICY-AVNRT (Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia)

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 572 (actual)
• Sponsor: Medtronic Cardiac Ablation Solutions · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

ICY-AVNRT (Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia) is a prospective multi-center, nonrandomized, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to demonstrate the safety and effectiveness of the Freezor® Xtra Cardiac CryoAblation Catheter for the cryoablation of the conducting tissues of the heart in the treatment of patients with atrioventricular nodal reentrant tachycardia (AVNRT) using an endocardial approach.

Conditions

• AtrioVentricular Nodal Reentrant Tachycardia
• Supraventricular Tachycardia
• Heart Disease

Interventions

Type	Name	Description
DEVICE	Freezor Xtra Cryoablation Catheter	Freezor® Xtra Cardiac CryoAblation applied for cryoablation of the conducting tissues of the heart in the treatment of patients with atrioventricular nodal reentrant tachycardia using an endocardial approach.

Timeline

• Start date: 2012-05-01
• Primary completion: 2015-09-01
• Completion: 2016-09-01
• First posted: 2011-08-31
• Last updated: 2025-02-13
• Results posted: 2017-03-31

Locations

34 sites across 2 countries: United States, Canada